arrow
P

Paola Muggeo

university hospital of policlinico of bari
H指数:16
被引数:807

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Epidemiology, impact on oncologic treatments, and management of community-acquired respiratory virus (CARV) infections in pediatric onco-hematology patients: a survey among Italian pediatric oncology hematology centres (AIEOP)

社区获得性呼吸道病毒(CARV)感染在儿科肿瘤血液病患者的流行病学、对肿瘤治疗的影响及管理:意大利儿科肿瘤血液学中心(AIEOP)的调查

2026-09-240
OA
A survey on the institutional practices of the use of isavuconazole in onco-hematological children, on behalf of the Infectious Working Group of AIEOP

代表AIEOP感染工作组对在血液肿瘤儿童中使用伊沙佐米的机构实践的调查

2026-09-230
OAAI
Cefiderocol in Children with Hematologic Malignancies—The Multicenter Retrospective Experience of the Infection Working Group of the Italian Pediatric Hematology and Oncology Association (AIEOP)

铁皮头孢菌素在血液恶性肿瘤儿童中的应用——意大利儿科血液与肿瘤学协会(AIEOP)感染工作组的多中心回顾性经验

2026-04-180
OAAI
Immunoprofiling, sex- and age-related determinants of treatment response in paediatric, adolescent and young adult Hodgkin lymphoma

免疫表型分析、性别和年龄对儿童、青少年及年轻成人心脏淋巴瘤治疗反应的影响因素

2026-03-120
OAAI
Recommendations for antibacterial prophylaxis in children receiving chemotherapy: a joint initiative of SITIP and infectious disease group of AIEOP

儿童化疗患者的抗菌预防建议:SITIP与AIEOP感染性疾病组的联合倡议

2025-11-250
OA
Correction to: Predictive and prognostic role of volumetric analyses and lymphoma dissemination in pediatric HL: a prospective, multicenter, cohort study

更正:体积分析和淋巴瘤扩散在儿童HL中的预测和预后作用:一项前瞻性、多中心、队列研究

2025-11-110
PRE
Real-Life Use of Posaconazole in Clinical Practice for Onco-Hematological Children: A National Survey by AIEOP Infectious Diseases Working Group

泊沙康唑在肿瘤血液学儿童中的临床实际应用:AIEOP感染性疾病工作组开展的一项全国性调查

2025-11-080
OAAI
Pediatric stewardship in Italy: a necessity, not an option - a National Multi-Society Expert Consensus on Antimicrobial and Diagnostic Stewardship (SIP, SITIP, SIMRI, SIAIP, SIMEUP, SIPPS, SICUPP, SIMIT, SIMPE, SIPINF, SIT, SIAATIP, SARNEPI, AIEOP, SIM, SITI, SIF, SIFACT, SITA, SIN)

意大利儿科医疗管理:一项必要性,而非选择——关于抗菌药物和诊断医疗管理的全国多学会专家共识(SIP, SITIP, SIMRI, SIAIP, SIMEUP, SIPPS, SICUPP, SIMIT, SIMPE, SIPINF, SIT, SIAATIP, SARNEPI, AIEOP, SIM, SITI, SIF, SIFACT, SITA, SIN)

2025-10-110
OAAI
The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP)

儿童接受化疗或造血细胞移植后血流感染的流行病学概况:意大利儿科血液学和肿瘤学协会(AIEOP)感染性疾病工作组进行的一项回顾性研究

2025-09-210
OAAI
Predictive and prognostic role of volumetric analyses and lymphoma dissemination in pediatric HL: a prospective, multicenter, cohort study

体积分析及淋巴瘤播散在儿童霍奇金淋巴瘤中的预测和预后作用:一项前瞻性、多中心、队列研究

2025-09-160
PRE
CD20-Negative Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphomas and Mature B-Cell Leukemia in Children, Adolescent and Young Adults: A Retrospective Review

CD20阴性复发/难治性成熟B细胞非霍奇金淋巴瘤和成熟B细胞白血病在儿童、青少年及年轻成人中的回顾性研究

BLOOD
IF23.1
2024-11-050
PRE
SARS-CoV-2 Infection in the Pediatric Oncology Population: The Definitive Comprehensive Report of the Infectious Diseases Working Group of AIEOP (vol 14, jiad496, 2023)
2024-03-220
OA
SARS-CoV-2 Infection in the Pediatric Oncology Population: The Definitive Comprehensive Report of the Infectious Diseases Working Group of AIEOP
2023-11-142
OA
Use of music therapy in pediatric oncology: an Italian AIEOP multicentric survey study in the era of COVID-19

音乐疗法在儿科肿瘤学中的应用: 新型冠状病毒肺炎时代的意大利aeop多中心调查研究

2022-11-302
OAAI
Oral Lactoferrin Supplementation during Induction Chemotherapy Promotes Gut Microbiome Eubiosis in Pediatric Patients with Hematologic Malignancies

诱导化疗期间口服乳铁蛋白可促进血液系统恶性肿瘤患儿的肠道菌群

2022-08-1617
OAAI
Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
2022-06-2019
OAAI
Consensus on COVID-19 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology Oncology
2022-02-247
OAAI